Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda. 2015

Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
Uganda Heart Institute, Mulago Hospital, P.O. Box 7051, Kampala, Uganda. jgnabbaale@gmail.com.

BACKGROUND Microalbuminuria is an early manifestation of kidney damage and independently predicts cardiovascular disease (CVD). Left ventricular hypertrophy (LVH) is also an early marker of cardiac manifestation of target organ damage among hypertensive patients. The prognostic significance of microalbuminuria and its correlation with left ventricular hypertrophy has not been extensively studied in African adult hypertensive populations. This study aimed at determining the prevalence of microalbuminuria, LVH in patients with microalbuminuria and the correlation between microalbuminuria and LVH among newly diagnosed black adult hypertensive patients attending a large outpatient hypertension clinic or admitted on the cardiology ward at Mulago national referral and teaching hospital and Uganda Heart Institute in Kampala, Uganda. METHODS In this cross-sectional study, 256 newly diagnosed eligible black adult hypertensive patients attending the outpatient hypertension clinic or admitted on the cardiology ward at Mulago national referral and teaching hospital and the Uganda Heart Institute, Kampala Uganda were consecutively recruited over a period of 5 months. Data on socio-demographics, clinical and laboratory findings of the study participants was collected using a pre tested questionnaire. Two spot urine samples were collected to assess for microalbuminuria. Echocardiography (ECHO) was done to assess for the left ventricular mass index using the formula of Teicholz as evidence for early hypertensive heart disease. RESULTS The mean age/standard deviation of the study participants was 54.3 ± 6.2 years with a female predominance (162, 63.3%). The prevalence of microalbuminuria among newly diagnosed hypertensive patients was 39.5%. The prevalence of LVH among patients with microalbuminuria was found to be 17%. There was a positive correlation between microalbuminuria and left ventricular hypertrophy among the newly diagnosed adult hypertensive patients at Mulago Hospital (r = 0.185, p = 0.003). CONCLUSIONS This study demonstrates that microalbuminuria is highly prevalent among newly diagnosed black hypertensive patients and in the presence of LVH. There is also a positive correlation between microalbuminuria and LVH among newly diagnosed hypertensive patients. Since it is a less costly and readily available test, it can be used to predict presence of LVH especially in resource limited settings where ECHO services are not readily available.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003710 Demography Statistical interpretation and description of a population with reference to distribution, composition, or structure. Demographer,Demographic,Demographic and Health Survey,Population Distribution,Accounting, Demographic,Analyses, Demographic,Analyses, Multiregional,Analysis, Period,Brass Technic,Brass Technique,Demographers,Demographic Accounting,Demographic Analysis,Demographic Factor,Demographic Factors,Demographic Impact,Demographic Impacts,Demographic Survey,Demographic Surveys,Demographic and Health Surveys,Demographics,Demography, Historical,Demography, Prehistoric,Factor, Demographic,Factors, Demographic,Family Reconstitution,Historical Demography,Impact, Demographic,Impacts, Demographic,Multiregional Analysis,Period Analysis,Population Spatial Distribution,Prehistoric Demography,Reverse Survival Method,Stable Population Method,Survey, Demographic,Surveys, Demographic,Analyses, Period,Analysis, Demographic,Analysis, Multiregional,Demographic Analyses,Demographies, Historical,Demographies, Prehistoric,Distribution, Population,Distribution, Population Spatial,Distributions, Population,Distributions, Population Spatial,Family Reconstitutions,Historical Demographies,Method, Reverse Survival,Method, Stable Population,Methods, Reverse Survival,Methods, Stable Population,Multiregional Analyses,Period Analyses,Population Distributions,Population Methods, Stable,Population Spatial Distributions,Prehistoric Demographies,Reconstitution, Family,Reconstitutions, Family,Reverse Survival Methods,Spatial Distribution, Population,Spatial Distributions, Population,Stable Population Methods,Technic, Brass,Technique, Brass
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2018, Journal of obesity and weight-loss medication,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
April 2010, The international journal of cardiovascular imaging,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2018, Cardiovascular journal of Africa,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2013, Clinical and experimental hypertension (New York, N.Y. : 1993),
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
March 2019, African health sciences,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
March 2002, Journal of hypertension,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2019, Clinical and experimental hypertension (New York, N.Y. : 1993),
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2011, Nigerian journal of clinical practice,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
June 2001, Annales de cardiologie et d'angeiologie,
Juliet Nabbaale, and Davis Kibirige, and Emmanuel Ssekasanvu, and Elias S Sebatta, and James Kayima, and Peter Lwabi, and Robert Kalyesubula
January 2004, The Journal of international medical research,
Copied contents to your clipboard!